Pfizer 3Q Net Falls Due to Generics, Higher Costs

29-10-2013 Comments (0)


Pfizer Inc.'s third-quarter profit dropped 19 percent as competition from generic drugs continued to cut sales, while lower operating expenses failed to offset higher taxes and charges. Like many other drugmakers, Pfizer is suffering as cheaper generic ...

More on this story...

Pfizer revenues down as patent losses hit sales

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top